Analysis of mRNA transcripts in chronic myeloid leukemia patients

Detalhes bibliográficos
Autor(a) principal: Meissner, Rosely de Vasconcellos
Data de Publicação: 1999
Outros Autores: Covas, Dimas T., Dias, Paula Menna Barreto, Job, Fani Martins, Leite, Marcia, Nardi, Nance Beyer
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/23491
Resumo: The nature of BCR/ABL hybrid mRNA was analyzed by RT-PCR in cells from 33 patients (22 males, 11 females) with chronic myeloid leukemia (CML). b3a2 mRNA was found in 14 cases, whereas 13 patients had b2a2 mRNA and six had both kinds of mRNA, with a predominance of the b3a2 type. The type of mRNA present showed no significant correlation with age, hemoglobin level, number of leukocytes and platelets, percentage of blasts or basophils or the presence of splenomegaly at diagnosis. There was also no correlation with sex or duration of the chronic phase. When these results were combined with those reported by other groups, a significant association (P = 0.029) was observed for mRNA type vs. sex, with a predominance of men in the groups expressing b2a2 (2.68:1) and b3a2 (1.33:1). We conclude that the classification of patients according to mRNA type does not homogenize the clinical and hematological data within groups, where variance is large, nor does it allow a differentiation between groups.
id UFRGS-2_25bae4542f2edc75c6aa328d826e2654
oai_identifier_str oai:www.lume.ufrgs.br:10183/23491
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Meissner, Rosely de VasconcellosCovas, Dimas T.Dias, Paula Menna BarretoJob, Fani MartinsLeite, MarciaNardi, Nance Beyer2010-06-08T04:17:58Z19991415-4757http://hdl.handle.net/10183/23491000293487The nature of BCR/ABL hybrid mRNA was analyzed by RT-PCR in cells from 33 patients (22 males, 11 females) with chronic myeloid leukemia (CML). b3a2 mRNA was found in 14 cases, whereas 13 patients had b2a2 mRNA and six had both kinds of mRNA, with a predominance of the b3a2 type. The type of mRNA present showed no significant correlation with age, hemoglobin level, number of leukocytes and platelets, percentage of blasts or basophils or the presence of splenomegaly at diagnosis. There was also no correlation with sex or duration of the chronic phase. When these results were combined with those reported by other groups, a significant association (P = 0.029) was observed for mRNA type vs. sex, with a predominance of men in the groups expressing b2a2 (2.68:1) and b3a2 (1.33:1). We conclude that the classification of patients according to mRNA type does not homogenize the clinical and hematological data within groups, where variance is large, nor does it allow a differentiation between groups.application/pdfengGenetics and molecular biology. Ribeirão Preto. Vol. 22, no. 4 (1999), p. 475-479.GenéticaAnalysis of mRNA transcripts in chronic myeloid leukemia patientsinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL000293487.pdf000293487.pdfTexto completo (inglês)application/pdf30288http://www.lume.ufrgs.br/bitstream/10183/23491/1/000293487.pdf021ad97ec5ea168e42a790c35ea57428MD51TEXT000293487.pdf.txt000293487.pdf.txtExtracted Texttext/plain26251http://www.lume.ufrgs.br/bitstream/10183/23491/2/000293487.pdf.txt9246ab784527a2dc59fa4a935912cb8eMD52THUMBNAIL000293487.pdf.jpg000293487.pdf.jpgGenerated Thumbnailimage/jpeg2041http://www.lume.ufrgs.br/bitstream/10183/23491/3/000293487.pdf.jpg15882c233116bc61b253215f7dff880fMD5310183/234912018-10-09 08:02:58.872oai:www.lume.ufrgs.br:10183/23491Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2018-10-09T11:02:58Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Analysis of mRNA transcripts in chronic myeloid leukemia patients
title Analysis of mRNA transcripts in chronic myeloid leukemia patients
spellingShingle Analysis of mRNA transcripts in chronic myeloid leukemia patients
Meissner, Rosely de Vasconcellos
Genética
title_short Analysis of mRNA transcripts in chronic myeloid leukemia patients
title_full Analysis of mRNA transcripts in chronic myeloid leukemia patients
title_fullStr Analysis of mRNA transcripts in chronic myeloid leukemia patients
title_full_unstemmed Analysis of mRNA transcripts in chronic myeloid leukemia patients
title_sort Analysis of mRNA transcripts in chronic myeloid leukemia patients
author Meissner, Rosely de Vasconcellos
author_facet Meissner, Rosely de Vasconcellos
Covas, Dimas T.
Dias, Paula Menna Barreto
Job, Fani Martins
Leite, Marcia
Nardi, Nance Beyer
author_role author
author2 Covas, Dimas T.
Dias, Paula Menna Barreto
Job, Fani Martins
Leite, Marcia
Nardi, Nance Beyer
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Meissner, Rosely de Vasconcellos
Covas, Dimas T.
Dias, Paula Menna Barreto
Job, Fani Martins
Leite, Marcia
Nardi, Nance Beyer
dc.subject.por.fl_str_mv Genética
topic Genética
description The nature of BCR/ABL hybrid mRNA was analyzed by RT-PCR in cells from 33 patients (22 males, 11 females) with chronic myeloid leukemia (CML). b3a2 mRNA was found in 14 cases, whereas 13 patients had b2a2 mRNA and six had both kinds of mRNA, with a predominance of the b3a2 type. The type of mRNA present showed no significant correlation with age, hemoglobin level, number of leukocytes and platelets, percentage of blasts or basophils or the presence of splenomegaly at diagnosis. There was also no correlation with sex or duration of the chronic phase. When these results were combined with those reported by other groups, a significant association (P = 0.029) was observed for mRNA type vs. sex, with a predominance of men in the groups expressing b2a2 (2.68:1) and b3a2 (1.33:1). We conclude that the classification of patients according to mRNA type does not homogenize the clinical and hematological data within groups, where variance is large, nor does it allow a differentiation between groups.
publishDate 1999
dc.date.issued.fl_str_mv 1999
dc.date.accessioned.fl_str_mv 2010-06-08T04:17:58Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/other
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/23491
dc.identifier.issn.pt_BR.fl_str_mv 1415-4757
dc.identifier.nrb.pt_BR.fl_str_mv 000293487
identifier_str_mv 1415-4757
000293487
url http://hdl.handle.net/10183/23491
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Genetics and molecular biology. Ribeirão Preto. Vol. 22, no. 4 (1999), p. 475-479.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/23491/1/000293487.pdf
http://www.lume.ufrgs.br/bitstream/10183/23491/2/000293487.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/23491/3/000293487.pdf.jpg
bitstream.checksum.fl_str_mv 021ad97ec5ea168e42a790c35ea57428
9246ab784527a2dc59fa4a935912cb8e
15882c233116bc61b253215f7dff880f
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801224719114960896